A nanoplatform with tumor-targeted aggregation and drug-specific release characteristics for photodynamic/photothermal combined antitumor therapy under near-infrared laser irradiation. Issue 21 (19th May 2020)

• Record Type: Journal Article
• Authors: Xie, Mingran; Zhu, Yongfu; Xu, Shibin; Xu, Guangwen; Xiong, Ran; Sun, Xiaohui; Liu, Changqing
• Is Part Of: Nanoscale. Volume 12:Issue 21(2020)
• Page Start: 11497
• Page End: 11509
• Publication Date: 2020-05-19
• Subjects: Nanoscience -- Periodicals; Nanotechnology -- Periodicals; 620.505
• DOI: 10.1039/d0nr00123f
• Languages: English
• ISSNs: 2040-3364

Abstract

Abstract : Due to their high biocompatibility, high spatial resolution and adjustable size and morphology, magnetic nanoparticles have become the most promising nanomaterials for clinical application in imaging and drug delivery for the treatment of cancers. Abstract : Due to their high biocompatibility, high spatial resolution, chromatographic capability, and adjustable size and morphology, magnetic nanoparticles have become the most promising nanomaterials for clinical application in noninvasive imaging and drug delivery for the treatment of malignant tumors. Herein, a novel magnetic nanoparticle coated with calcium carbonate was prepared and loaded with near-infrared drugs to be used as a multifunctional theranostic nanoplatform for the diagnosis and treatment of malignant tumors. Then, these drug-loaded nanoparticles were used for combined photodynamic/photothermal therapy by intravenous administration that was simultaneously guided by fluorescence/MR imaging. Due to the targeted induction of the external magnetic field and tumor response degradation of the calcium carbonate layer, the nanoprobe demonstrated excellent tumor targeting and greatly improved drug aggregation at the tumor site. Finally, single wavelength-mediated photothermal/photodynamic therapy was applied to liver cancer model mice, ultimately achieving an exciting antitumor therapeutic effect. This study may promote further exploration of nanoplatforms based on magnetic nanoparticles for clinical application in the treatment of malignant tumors.